Definiens is the leading provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives.
Parent Company
München, DE
Definiens was founded in 1994 and is headquartered in München, DE

Key People/Management at Definiens

Thomas P. Heydler

Thomas P. Heydler

Chairman & CEO
Markus Rinecker

Markus Rinecker


Definiens Office Locations

Definiens has offices in München, Carlsbad, Cambridge, Munich and in 1 other location
München, DE (HQ)
Bernhard-Wicki-Strasse 5
Cambridge, US
300 125 Cambridge Park Dr
Carlsbad, US
190 1808 Aston Ave

Definiens Financials and Metrics

Definiens Summary

Founding Date


Total Funding

$33.3 m


Definiens is a subsidiary of AstraZeneca

Definiens's Web-traffic and Trends

Definiens Online and Social Media Presence

Definiens Company Life and Culture

You may also be interested in